We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+23.43%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.4B
AUM Growth
-$5.58B
(-25%)
Cap. Flow
-$3.87B
Cap. Flow
% of AUM
-23.65%
Top 10 Holdings %
Top 10 Hldgs %
18.07%
Holding
3,458
New
283
Increased
974
Reduced
1,077
Closed
907
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$97.1M |
| 2 |
iShares Core S&P Small-Cap ETF
IJR
|
+$76.6M |
| 3 |
Lowe's Companies
LOW
|
+$75.4M |
| 4 |
Monster Beverage
MNST
|
+$64.6M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$63.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$114M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$109M |
| 3 |
Trane Technologies
TT
|
+$106M |
| 4 |
Microsoft
MSFT
|
+$104M |
| 5 |
Mastercard
MA
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Healthcare | 13.89% |
| 3 | Financials | 11.27% |
| 4 | Consumer Discretionary | 8.92% |
| 5 | Industrials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Globus Medical
GMED
$11.1B
| $327K | ﹤0.01% |
6,861
+1,455
| +27% | +$70.2K |
|
877
iShares US Financials ETF
IYF
$4.65B
| $326K | ﹤0.01% |
5,932
+2,860
| +93% | +$153K |
|
878
Princeton Bancorp
BPRN
$283M
| $325K | ﹤0.01% |
16,200
| – | – |
|
879
Curtiss-Wright
CW
$25.1B
| $325K | ﹤0.01% |
3,658
-9,620
| -72% | -$917K |
|
880
Leggett & Platt
LEG
$1.4B
| $325K | ﹤0.01% |
9,256
-2,596
| -22% | -$80.5K |
|
881
Mohawk Industries
MHK
$6.91B
| $325K | ﹤0.01% |
3,195
-4,253
| -57% | -$374K |
|
882
NGL Energy Partners
NGL
$1.94B
| $325K | ﹤0.01% |
83,468
-33,493
| -29% | -$157K |
|
883
Nutrien
NTR
$33.9B
| $324K | ﹤0.01% |
10,123
-6,479
| -39% | -$225K |
|
|
DCPH
884
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $323K | ﹤0.01% |
5,424
+1,175
| +28% | +$62.9K |
|
885
Maximus
MMS
$3.32B
| $322K | ﹤0.01% |
4,585
-48,532
| -91% | -$3.26M |
|
886
Occidental Petroleum
OXY
$55.7B
| $321K | ﹤0.01% |
17,597
-58,223
| -77% | -$917K |
|
887
Valley National Bancorp
VLY
$7.9B
| $321K | ﹤0.01% |
41,179
-9,549
| -19% | -$73.3K |
|
888
Check Point Software Technologies
CHKP
$14.3B
| $320K | ﹤0.01% |
2,988
-358
| -11% | -$37.9K |
|
889
Provident Financial Services
PFS
$3.14B
| $319K | ﹤0.01% |
22,144
-16,428
| -43% | -$220K |
|
890
RBC Bearings
RBC
$17.4B
| $317K | ﹤0.01% |
2,370
-16
| -0.7% | -$2.04K |
|
891
Mueller Water Products
MWA
$3.94B
| $313K | ﹤0.01% |
33,284
-12,975
| -28% | -$116K |
|
892
Alarm.com
ALRM
$2.75B
| $312K | ﹤0.01% |
4,822
+4,553
| +1,693% | +$229K |
|
893
Interparfums
IPAR
$4.07B
| $312K | ﹤0.01% |
6,486
-5,523
| -46% | -$249K |
|
|
IPG
894
DELISTED
Interpublic Group of Companies
IPG
| $312K | ﹤0.01% |
18,265
-36,443
| -67% | -$601K |
|
895
Equinor
EQNR
$97.3B
| $310K | ﹤0.01% |
21,452
-12,152
| -36% | -$171K |
|
|
KRTX
896
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $310K | ﹤0.01% |
2,785
+595
| +27% | +$51.7K |
|
897
Pembina Pipeline
PBA
$29.3B
| $309K | ﹤0.01% |
12,425
+1,575
| +15% | +$36.4K |
|
898
IDEX
IEX
$17B
| $307K | ﹤0.01% |
1,946
-5,216
| -73% | -$797K |
|
|
AIMC
899
DELISTED
Altra Industrial Motion Corp
AIMC
| $307K | ﹤0.01% |
9,640
+9,573
| +14,288% | +$253K |
|
900
Diamondrock Hospitality Co
DRH
$2.68B
| $306K | ﹤0.01% |
55,504
+53,756
| +3,075% | +$296K |
|
Similar funds
EWA
MIC
P
OSAM
CB
EIM
SC
Glenmede Trust's Q2 2020 Portfolio in Review
As of Q2 2020, Glenmede Trust held 3,458 positions worth $16.4B, down 25% from $21.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Glenmede Trust withdrew a net $3.87B in Q2 2020, closing 907 positions and reducing 1,077 holdings. Its most notable exit was Raytheon Company, an estimated $66.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Glenmede Trust opened a new position in Carrier Global worth $21.3M.
- Glenmede Trust's largest Q2 2020 buy was Carrier Global: 960,042 shares worth $21.3M.
- Glenmede Trust added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $97.1M increase.
- Glenmede Trust's biggest Q2 2020 reduction was Accenture, cutting an estimated $114M.
- Glenmede Trust fully exited Raytheon Company in Q2 2020, selling an estimated $66.5M.
- Glenmede Trust's ten largest holdings make up 18% of its $16.4B portfolio in Q2 2020.
- Glenmede Trust opened 283 new positions and closed 907 in Q2 2020.
- Glenmede Trust's portfolio value fell 25% quarter-over-quarter to $16.4B.
Based on Glenmede Trust's 13F filing for Q2 2020, filed 14 Aug 2020.